High Dose Omeprazole in Patients With Pancreatic Cancer
NCT04930991
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Exocrine Pancreatic Cancer
Interventions
DRUG:
Omeprazole
Sponsor
University of Oklahoma